Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues

Kamp P-B, Strathmann A, Ragg H (2001)
THROMBOSIS RESEARCH 101(6): 483-491.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Abstract / Bemerkung
In the presence of glycosaminoglycans, thrombin is rapidly inactivated by two natural inhibitors secreted from liver: antithrombin (AT) is presumed to be the principal thrombin inhibitor in circulating blood, while for heparin cofactor II (HCII), a role outside circulation has been proposed. In this study, we show that HCII and AT differ with respect to their association with human tissues. Aside from brain, each of these inhibitors was found in sodium dodecyl sulphate (SDS) soluble extracts of various human organs, with a preponderance of HCII in placenta. AT levels, however, predominated in liver. Compared to plasma, the beta -variant of AT was found to be strongly enriched in human organs, while tissue-resident HCII did not differ in its electrophoretic mobility from the circulating form. In placenta, comparable amounts of HCII/thrombin and AT/thrombin complexes were detected, indicating that HCII may exert a thrombin regulating role in that organ under conditions of tissue or blood vessel damage. Transcripts coding for HCII and AT were detected in all tissues examined. The low levels of their mRNAs suggest that most of the tissue-associated thrombin inhibitor molecules originate from circulation and are retained in organs, possibly by specific receptors. The differential presence of HCII and AT in organs is in accordance with individual physiological roles of these inhibitors. (C) 2001 Elsevier Science Ltd. All rights reserved.
Erscheinungsjahr
Zeitschriftentitel
THROMBOSIS RESEARCH
Band
101
Ausgabe
6
Seite(n)
483-491
ISSN
PUB-ID

Zitieren

Kamp P-B, Strathmann A, Ragg H. Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues. THROMBOSIS RESEARCH. 2001;101(6):483-491.
Kamp, P. - B., Strathmann, A., & Ragg, H. (2001). Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues. THROMBOSIS RESEARCH, 101(6), 483-491. doi:10.1016/S0049-3848(00)00422-9
Kamp, P. - B., Strathmann, A., and Ragg, H. (2001). Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues. THROMBOSIS RESEARCH 101, 483-491.
Kamp, P.-B., Strathmann, A., & Ragg, H., 2001. Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues. THROMBOSIS RESEARCH, 101(6), p 483-491.
P.-B. Kamp, A. Strathmann, and H. Ragg, “Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues”, THROMBOSIS RESEARCH, vol. 101, 2001, pp. 483-491.
Kamp, P.-B., Strathmann, A., Ragg, H.: Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues. THROMBOSIS RESEARCH. 101, 483-491 (2001).
Kamp, Paul-Bertram, Strathmann, Annemarie, and Ragg, Hermann. “Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues”. THROMBOSIS RESEARCH 101.6 (2001): 483-491.

7 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer.
Liao WY, Ho CC, Hou HH, Hsu TH, Tsai MF, Chen KY, Chen HY, Lee YC, Yu CJ, Lee CH, Yang PC., J Pathol 235(1), 2015
PMID: 25130770
Effect of microgravity on gene expression in mouse brain.
Frigeri A, Iacobas DA, Iacobas S, Nicchia GP, Desaphy JF, Camerino DC, Svelto M, Spray DC., Exp Brain Res 191(3), 2008
PMID: 18704384
Heparin cofactor II modulates the response to vascular injury.
Tollefsen DM., Arterioscler Thromb Vasc Biol 27(3), 2007
PMID: 17194895
Fatal thrombosis of antithrombin-deficient mice is rescued differently in the heart and liver by intercrossing with low tissue factor mice.
Hayashi M, Matsushita T, Mackman N, Ito M, Adachi T, Katsumi A, Yamamoto K, Takeshita K, Kojima T, Saito H, Murohara T, Naoe T., J Thromb Haemost 4(1), 2006
PMID: 16409467
Adenovirus-mediated expression of heparin cofactor II inhibits thrombin-induced cellular responses in fibroblasts and vascular smooth muscle cells.
Hayakawa Y, Hirashima Y, Yamamoto H, Hayashi N, Kurimoto M, Kuwayama N, Endo S., Thromb Res 116(4), 2005
PMID: 16038721
Localization of heparin cofactor II in injured human skin: a potential role in wound healing.
Hoffman M, Loh KL, Bond VK, Palmieri D, Ryan JL, Church FC., Exp Mol Pathol 75(2), 2003
PMID: 14516771

40 References

Daten bereitgestellt von Europe PubMed Central.

The clot thickens: clues provided by thrombin structure.
Stubbs MT, Bode W., Trends Biochem. Sci. 20(1), 1995
PMID: 7878739
On the activation of human leuserpin-2, a thrombin inhibitor, by glycosaminoglycans.
Ragg H, Ulshofer T, Gerewitz J., J. Biol. Chem. 265(9), 1990
PMID: 2318889
Glycosaminoglycan-mediated leuserpin-2/thrombin interaction. Structure-function relationships.
Ragg H, Ulshofer T, Gerewitz J., J. Biol. Chem. 265(36), 1990
PMID: 2266131
Inhibition of dysthrombins Quick I and II by heparin cofactor II and antithrombin.
Phillips JE, Shirk RA, Whinna HC, Henriksen RA, Church FC., J. Biol. Chem. 268(5), 1993
PMID: 8429008
Association of hereditary heparin co-factor II deficiency with thrombosis.
Tran TH, Marbet GA, Duckert F., Lancet 2(8452), 1985
PMID: 2863444
Constitutional heparin co-factor II deficiency associated with recurrent thrombosis.
Sie P, Dupouy D, Pichon J, Boneu B., Lancet 2(8452), 1985
PMID: 2863445
Hereditary heparin cofactor II deficiency and thrombosis: report of six patients belonging to two separate kindreds
Simioni, Blood Coagulation Fibrinolysis 1(), 1990
Hereditary heparin cofactor II deficiency and the risk of development of thrombosis
Bertina, Thromb Haemostasis 57(), 1987
Structure and expression of the gene coding for the human serpin hLS2.
Ragg H, Preibisch G., J. Biol. Chem. 263(24), 1988
PMID: 2841345
Murine heparin cofactor II: purification, cDNA sequence, expression, and gene structure.
Zhang GS, Mehringer JH, Van Deerlin VM, Kozak CA, Tollefsen DM., Biochemistry 33(12), 1994
PMID: 7908224
Heparin cofactor II levels are increased by the use of combined oral contraceptives
Mackie, Blood Coagulation Fibrinolysis 1(), 1990
Heparin cofactor II activity in plasma during pregnancy and oral contraceptive use.
Massouh M, Jatoi A, Gordon EM, Ratnoff OD., J. Lab. Clin. Med. 114(6), 1989
PMID: 2592856
Increased heparin cofactor II levels in women taking oral contraceptives
Toulon, Thromb Haemostasis 64(), 1990
Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis
Toulon, Blood Coagulation Fibrinolysis 2(), 1991
Physiological variant of antithrombin-III lacks carbohydrate sidechain at Asn 135.
Brennan SO, George PM, Jordan RE., FEBS Lett. 219(2), 1987
PMID: 3609301
The mechanisms of action of α- and β-isoforms of antithrombin
Swedenborg, Blood Coagulation Fibrinolysis 9(Suppl. 3), 1998
Vascular-bed--specific hemostasis and hypercoagulable states.
Rosenberg RD, Aird WC., N. Engl. J. Med. 340(20), 1999
PMID: 10332019
Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II.
Shirk RA, Church FC, Wagner WD., Arterioscler. Thromb. Vasc. Biol. 16(9), 1996
PMID: 8792767
Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding
Zacharski, Thromb Haemostasis 73(), 1995
A new member of the plasma protease inhibitor gene family.
Ragg H., Nucleic Acids Res. 14(2), 1986
PMID: 3003690
Antithrombin: structure and function
Sheffield, 1995
Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo
Liu, Thromb Haemostasis 73(), 1995
Familial overexpression of beta antithrombin caused by an Asn135Thr substitution.
Bayston TA, Tripodi A, Mannucci PM, Thompson E, Ireland H, Fitches AC, Hananeia L, Olds RJ, Lane DA., Blood 93(12), 1999
PMID: 10361121
Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin.
Edmunds T, Van Patten SM, Pollock J, Hanson E, Bernasconi R, Higgins E, Manavalan P, Ziomek C, Meade H, McPherson JM, Cole ES., Blood 91(12), 1998
PMID: 9616152
Thrombin-inhibitor complexes in the blood during and after delivery.
Andersson T, Lorentzen B, Hogdahl H, Clausen T, Mowinckel MC, Abildgaard U., Thromb. Res. 82(2), 1996
PMID: 9163064
An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.
Andrew M, Mitchell L, Berry L, Paes B, Delorme M, Ofosu F, Burrows R, Khambalia B., J. Clin. Invest. 89(1), 1992
PMID: 1729278
Anticoagulant dermatan sulfate proteoglycan (decorin) in the term human placenta.
Delorme MA, Xu L, Berry L, Mitchell L, Andrew M., Thromb. Res. 90(4), 1998
PMID: 9692613
Interaction of heparin cofactor II with biglycan and decorin.
Whinna HC, Choi HU, Rosenberg LC, Church FC., J. Biol. Chem. 268(6), 1993
PMID: 8440685
Cell biology of arterial proteoglycans.
Wight TN., Arteriosclerosis 9(1), 1989
PMID: 2643420
Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells.
McGuire EA, Tollefsen DM., J. Biol. Chem. 262(1), 1987
PMID: 3793724
Regulation of extravascular coagulation by microvascular permeability.
Dvorak HF, Senger DR, Dvorak AM, Harvey VS, McDonagh J., Science 227(4690), 1985
PMID: 3975602
Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis.
Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM., Curr. Top. Microbiol. Immunol. 237(), 1999
PMID: 9893348
Cloning and expression of the cDNA for human antithrombin III.
Bock SC, Wion KL, Vehar GA, Lawn RM., Nucleic Acids Res. 10(24), 1982
PMID: 6298709

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 11323006
PubMed | Europe PMC

Suchen in

Google Scholar